-+ 0.00%
-+ 0.00%
-+ 0.00%

Vor Biopharma Q4 Adj. EPS $(1.63) Beats $(1.64) Estimate

Benzinga·03/30/2026 13:29:54
Listen to the news
Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(1.63) per share which beat the analyst consensus estimate of $(1.64) by 0.61 percent. This is a 81.48 percent increase over losses of $(8.80) per share from the same period last year.